Find answers to all your questions on live NAVNETEDUL message board: Is NAVNETEDUL buy or sell? Should I buy NAVNETEDUL shares? Why are NAVNETEDUL shares falling? Should I invest in NAVNETEDUL stock?
Accumulate Navneet Education; target of Rs 93: Prabhudas Lilladher Prabhudas Lilladher recommended accumulate rating on Navneet Education with a target price of Rs 93 in its research report dated November 11, 2020.
Hold Natco Pharma; target of Rs 970: ICICI Direct ICICI Direct recommended hold rating on Natco Pharma with a target price of Rs 970 in its research report dated November 13, 2020.
Natco Pharma Q2 net profit up 73% to Rs 204 crore The company had posted a net profit of Rs 117.7 crore for the corresponding period of the previous fiscal, Natco Pharma said in a BSE filing.
Natco Pharma aims to diversify product portfolio in domestic market New Delhi, Sep 21 Natco Pharma plans to diversify its product portfolio in the domestic market as it aims to make up for a drop in business of some..
Buy Natco Pharma: target of Rs 954: ICICI Securities ICICI Securities is bullish on Natco Pharma recommended buy rating on the stock with a target price of Rs 954 in its research report dated September 18, 2020.
Hold Natco Pharma; target of Rs 881: Geojit Geojit recommended accumulate rating on Natco Pharma with a target price of Rs 881 in its research report dated August 14, 2020.
Accumulate Navneet Education; target of Rs 94: Prabhudas Lilladher Prabhudas Lilladher recommended accumulate rating on Navneet Education with a target price of Rs 94 in its research report dated August 13, 2020.
Buy Natco Pharma; target of Rs 950: ICICI Direct ICICI Direct is bullish on Natco Pharma has recommended buy rating on the stock with a target price of Rs 950 in its research report dated August 13, 2020.
Natco Pharma Q1 net profit declines 14.5% to Rs 122 crore The company had posted a net profit of Rs 142.8 crore for the corresponding period of the previous fiscal, Natco Pharma said in a BSE filing.
Hot Stocks | Natco Pharma, Godrej Properties two buy calls for short-term The actual weakness would start only if Nifty sustains below 10,870, till then, one should continue with a stock-specific positive bias.
Hot Stocks | Natco Pharma, IRB Infra two buy calls for the short term As we step into the monthly expiry week, our eyes would be on a few crucial levels. On the upside, 11,250 is the level to watch out for, whereas, 11,050 has now become key support.
Top stocks to bet on: ICICI Bank, Biocon, Rallis India can return 15-20% in near term On the upside, the Nifty needs to sustain 10,800 for the uptrend to continue towards 11,100 and then possibly 11,350.
Hot Stocks | Natco Pharma, NCC, Century Textiles three short-term buy calls On the weekly chart, Nifty has formed a bullish higher top higher bottom pattern. A similar pattern is also observed in the Midcap and Smallcap indices, indicating broad-based rally in the markets.
Buy Natco Pharma; target of Rs 740: ICICI Direct ICICI Direct is bullish on Natco Pharma has recommended buy rating on the stock with a target price of Rs 740 in its research report dated June 19, 2020.
Buy Navneet Education; target of Rs 95: ICICI Direct ICICI Direct is bullish on Navneet Education has recommended buy rating on the stock with a target price of Rs 95 in its research report dated June 15, 2020.
Hold Navneet Education; target of Rs 89: Prabhudas Lilladher Prabhudas Lilladher recommended Hold rating on Navneet Education with a target price of Rs 89 in its research report dated June 18, 2020.
Natco Pharma's Q4 net profit falls 22%; shares drop 3% Consolidated revenue declined marginally by 0.2 percent YoY to Rs 454.8 crore in Q4FY20 against Rs 455.7 crore in Q4FY19.
Coronavirus pandemic | Natco Pharma donates chloroquine tablets for global trials The trial will examine whether the anti-malarial drug can protect essential healthcare workers from COVID-19 virus.
Stocks in the news: VST Tillers Tractors, Karur Vysya Bank, Vakrangee, NTPC, Emami VST Tillers Tractors | Karur Vysya Bank | Vakrangee | NTPC | Emami and NLC India are among the stocks that are in the news today.
Trade Setup for Thursday: Top 15 things to know before Opening Bell Key support level for Nifty is placed at 8208.05, followed by 7947.3. If the index moves up, key resistance levels to watch out for are 8928.55 and 9388.3.
Natco Pharma Q3 net profit declines 34% to Rs 104.4cr Consolidated total income stood at Rs 513 crore for the quarter under consideration. It was Rs 580 crore for the same period a year ago.
Budget 2020: Rs 99,300 crore set aside for education sector; Navneet Education, NIIT in focus Government to source more ECB & FDI for the education sector, says FM Nirmala Sitharaman.
Natco Pharma gets EIR from USFDA for Hyderabad facility In a BSE filing, Natco Pharma announced "successful closure of inspection" with the receipt of an establishment inspection report (EIR) from the US Food and Drug Administration (USFDA) for the inspection conducted at its active pharmaceutical ingredient (API) facility in Mekaguda Village, near Hyderabad, India.
Buy Navneet Education; target of Rs 130: ICICI Direct ICICI Direct is bullish on Navneet Education has recommended buy rating on the stock with a target price of Rs 130 in its research report dated August 12, 2019.
Hold Natco Pharma; target of Rs 595: ICICI Direct ICICI Direct recommended hold rating on Natco Pharma with a target price of Rs 595 in its research report dated August 12, 2019.
Buy Navneet Education; target of Rs 134: Prabhudas Lilladher Prabhudas Lilladher is bullish on Navneet Education has recommended buy rating on the stock with a target price of Rs 134 in its research report date August 09, 2019.
Natco Pharma gets EIR from USFDA for Kothur facility The receipt of EIR from the United States Food and Drug Administration (USFDA) indicates the successful closure of inspection of the company’s drug formulations facility in Kothur, Natco Pharma said in a BSE filing.
Stocks in the news: ICICI Bank, Cadila Health, Mahindra Life, Vedanta, Uflex, Granules, NHPC Maruti Suzuki | Allahabad Bank | Future Lifestyle Fashions | ICICI Bank | Power Mech Projects | Manpasand Beverages and Usha Martin are stocks which are in news today.
Stocks in the news: ICICI Bank, Cadila Health, Mahindra Life, Vedanta, Uflex, Granules India Maruti Suzuki | Allahabad Bank | Future Lifestyle Fashions | ICICI Bank | Power Mech Projects | Manpasand Beverages and Usha Martin are stocks which are in news today.
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.